Cannell & Spears’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,255
Closed -$222K 242
2021
Q3
$222K Hold
5,255
0.02% 219
2021
Q2
$241K Buy
+5,255
New +$250K 0.02% 217

Other funds holding NRC

Cannell & Spears's NRC Position: Q4 2021 in Review

Cannell & Spears sold out of NRC Health Common Stock (NRC) in Q4 2021, closing a stake of 5,255 shares — an estimated $222K sold.

Cannell & Spears first reported a position in NRC in Q2 2021 and held it in 2 quarters. The position peaked at $241K in Q2 2021. 113 funds tracked by Wall St. Rank hold NRC as of Q4 2021.

  • Cannell & Spears reported no remaining NRC Health Common Stock position as of Q4 2021 after selling out during the quarter.
  • Cannell & Spears sold 5,255 NRC Health Common Stock shares in Q4 2021, an estimated $222K.
  • Cannell & Spears first reported a position in NRC Health Common Stock in Q2 2021 and held it in 2 quarters.
  • Cannell & Spears's NRC Health Common Stock position peaked at $241K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2021.

Based on Cannell & Spears's 13F filing for Q4 2021, filed 14 Feb 2022.